Publications:

---

Progressing Vulvar Melanoma Caused by Instability in cKIT Juxtamembrane Domain: A Case Report and Review of Literature.

Current Oncology (Toronto, Ont.)

Englert-Golon, Monika M; Budny, Bartłomiej B; Lewandowska, Małgorzata M; Burchardt, Bartosz B; Smolarek, Natalia N; Ziemnicka, Katarzyna K; Jagodziński, Paweł Piotr PP; Ruchała, Marek M; Grabowska, Marlena M; Sajdak, Stefan S

Publication Date: 2022-04-29

Variant appearance in text: ERBB2: V777A

PubMed Link: 35621644

Variant Present in the following documents:

• curroncol-29-00254.pdf

View BVdb publication page

---

Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.

Frontiers In Endocrinology

Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C

Publication Date: 2021

Variant appearance in text: ERBB2: V777A

PubMed Link: 34630336

Variant Present in the following documents:

• Table_1.xlsx, sheet 2

View BVdb publication page

---

Mutation profile and immunoscore signature in thymic carcinomas: An exploratory study and review of the literature.

Thoracic Cancer

Asselta, Rosanna R; Di Tommaso, Luca L; Perrino, Matteo M; Destro, Annarita A; Giordano, Laura L; Cardamone, Giulia G; Rubino, Luca L; Santoro, Armando A; Duga, Stefano S; Zucali, Paolo Andrea PA

Publication Date: 2021-05

Variant appearance in text: ERBB2: 2330T>C; V777A

PubMed Link: 33704917

Variant Present in the following documents:

• TCA-12-1271-s003.xls, sheet 1

View BVdb publication page

---

Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.

Gastric Cancer : Official Journal Of The International Gastric Cancer Association And The Japanese Gastric Cancer Association

Hescheler, Daniel A DA; Plum, Patrick S PS; Zander, Thomas T; Quaas, Alexander A; Korenkov, Michael M; Gassa, Asmae A; Michel, Maximilian M; Bruns, Christiane J CJ; Alakus, Hakan H

Publication Date: 2020-07

Variant appearance in text: ERBB2: V777A

PubMed Link: 32107691

Variant Present in the following documents:

• 10120_2020_1045_MOESM1_ESM.xlsx, sheet 12

View BVdb publication page

---

Frequency, impact and a preclinical study of novel ERBB gene family mutations in HER2-positive breast cancer.

Therapeutic Advances In Medical Oncology

Elster, Naomi N; Toomey, Sinead S; Fan, Yue Y; Cremona, Mattia M; Morgan, Clare C; Weiner Gorzel, Karolina K; Bhreathnach, Una U; Milewska, Malgorzata M; Murphy, Madeline M; Madden, Stephen S; Naidoo, Jarushka J; Fay, Joanna J; Kay, Elaine E; Carr, Aoife A; Kennedy, Sean S; Furney, Simon S; Mezynski, Janusz J; Breathhnach, Oscar O; Morris, Patrick P; Grogan, Liam L; Hill, Arnold A; Kennedy, Susan S; Crown, John J; Gallagher, William W; Hennessy, Bryan B; Eustace, Alex A

Publication Date: 2018

Variant appearance in text: HER2: V777A

PubMed Link: 30023006

Variant Present in the following documents:

• Supplementary_material.pdf

View BVdb publication page

---

Genomic alterations of ERBB receptors in cancer: clinical implications.

Oncotarget

Mishra, Rosalin R; Hanker, Ariella B AB; Garrett, Joan T JT

Publication Date: 2017-12-26

Variant appearance in text: ERBB2: V777A

PubMed Link: 29371993

Variant Present in the following documents:

• Main text
• oncotarget-08-114371.pdf

View BVdb publication page

---

Longitudinal analysis of treatment-induced genomic alterations in gliomas.

Genome Medicine

Erson-Omay, E Zeynep EZ; Henegariu, Octavian O; Omay, S Bülent SB; Harmancı, Akdes Serin AS; Youngblood, Mark W MW; Mishra-Gorur, Ketu K; Li, Jie J; Özduman, Koray K; Carrión-Grant, Geneive G; Clark, Victoria E VE; Çağlar, Caner C; Bakırcıoğlu, Mehmet M; Pamir, M Necmettin MN; Tabar, Viviane V; Vortmeyer, Alexander O AO; Bilguvar, Kaya K; Yasuno, Katsuhito K; DeAngelis, Lisa M LM; Baehring, Joachim M JM; Moliterno, Jennifer J; Günel, Murat M

Publication Date: 2017-02-02

Variant appearance in text: ERBB2: V777A

PubMed Link: 28153049

Variant Present in the following documents:

• 13073_2017_401_MOESM3_ESM.xlsx, sheet 2

View BVdb publication page

---

ERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomas.

Oncotarget

Deniziaut, Gabrielle G; Tille, Jean Christophe JC; Bidard, François-Clément FC; Vacher, Sophie S; Schnitzler, Anne A; Chemlali, Walid W; Trémoulet, Laurence L; Fuhrmann, Laetitia L; Cottu, Paul P; Rouzier, Roman R; Bièche, Ivan I; Vincent-Salomon, Anne A

Publication Date: 2016-11-08

Variant appearance in text: ERBB2: 2330T>C; V777A

PubMed Link: 27602491

Variant Present in the following documents:

• Main text
• oncotarget-07-73337-s001.pdf
• oncotarget-07-73337.pdf

View BVdb publication page

---

Pyrosequencing-Based Assays for Rapid Detection of HER2 and HER3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting HER3 in Retroperitoneal Leiomyosarcoma.

International Journal Of Molecular Sciences

González-Alonso, Paula P; Chamizo, Cristina C; Moreno, Víctor V; Madoz-Gúrpide, Juan J; Carvajal, Nerea N; Daoud, Lina L; Zazo, Sandra S; Martín-Aparicio, Ester E; Cristóbal, Ion I; Rincón, Raúl R; García-Foncillas, Jesús J; Rojo, Federico F

Publication Date: 2015-08-17

Variant appearance in text: HER2: V777A

PubMed Link: 26287187

Variant Present in the following documents:

• Main text

View BVdb publication page

---

HER2 as a target in invasive urothelial carcinoma.

Cancer Medicine

Bellmunt, Joaquim J; Werner, Lillian L; Bamias, Aristotle A; Fay, André P AP; Park, Rachel S RS; Riester, Markus M; Selvarajah, Shamini S; Barletta, Justine A JA; Berman, David M DM; de Muga, Silvia S; Salido, Marta M; Gallardo, Enrique E; Rojo, Federico F; Guancial, Elizabeth A EA; Bambury, Richard R; Mullane, Stephanie A SA; Choueiri, Toni K TK; Loda, Massimo M; Stack, Edward E; Rosenberg, Jonathan J

Publication Date: 2015-06

Variant appearance in text: HER2: V777A

PubMed Link: 25720673

Variant Present in the following documents:

• Main text
• cam40004-0844.pdf

View BVdb publication page

---

Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations.

Genome Biology

Martelotto, Luciano G LG; Ng, Charlotte Ky CK; De Filippo, Maria R MR; Zhang, Yan Y; Piscuoglio, Salvatore S; Lim, Raymond S RS; Shen, Ronglai R; Norton, Larry L; Reis-Filho, Jorge S JS; Weigelt, Britta B

Publication Date: 2014-10-28

Variant appearance in text: ERBB2: V777A

PubMed Link: 25348012

Variant Present in the following documents:

• 13059_2014_484_MOESM2_ESM.xlsx, sheet 1

View BVdb publication page

---

Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System.

Clinical Medicine Insights. Oncology

Nieto-Sampedro, Manuel M; Valle-Argos, Beatriz B; Gómez-Nicola, Diego D; Fernández-Mayoralas, Alfonso A; Nieto-Díaz, Manuel M

Publication Date: 2011

Variant appearance in text: ERBB2: V777A

PubMed Link: 22084619

Variant Present in the following documents:

• Main text
• cmo-5-2011-265.pdf

View BVdb publication page

---

Predicting the functional impact of protein mutations: application to cancer genomics.

Nucleic Acids Research

Reva, Boris B; Antipin, Yevgeniy Y; Sander, Chris C

Publication Date: 2011-09-01

Variant appearance in text: ERBB2: V777A

PubMed Link: 21727090

Variant Present in the following documents:

• supp_gkr407_Supplement2_Table_SM1_COSMIC_mutations.xls, sheet 1

View BVdb publication page

---

Comprehensive genomic characterization defines human glioblastoma genes and core pathways.

Nature

,

Publication Date: 2008-10-23

Variant appearance in text: ERBB2: V777A

PubMed Link: 18772890

Variant Present in the following documents:

• Main text
• nihms68048.pdf

View BVdb publication page

---